Allist(SH:688578) Xin Lang Zheng Quan·2026-01-09 03:25Group 1 - The core viewpoint of the news is that Ailis has shown a positive performance in stock price and financial results, indicating growth potential in the pharmaceutical sector [1][2][3] - As of January 9, Ailis's stock price increased by 2.02% to 106.30 CNY per share, with a total market capitalization of 47.835 billion CNY [1] - The company reported a revenue of 3.733 billion CNY for the first nine months of 2025, representing a year-on-year growth of 47.35%, and a net profit of 1.616 billion CNY, up 52.01% year-on-year [2] Group 2 - Ailis has a total of 19,100 shareholders as of September 30, 2025, which is an increase of 46.82% compared to the previous period [2] - The company has distributed a total of 653 million CNY in dividends since its A-share listing [3] - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited holding 20.9471 million shares, an increase of 10.5693 million shares from the previous period [3]